These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 6216781)

  • 1. Thromboxane a2: biosynthesis and effects on platelets.
    Granström E; Diczfalusy U; Hamberg M; Hansson G; Malmsten C; Samuelsson B
    Adv Prostaglandin Thromboxane Leukot Res; 1982; 10():15-58. PubMed ID: 6216781
    [No Abstract]   [Full Text] [Related]  

  • 2. Heparin potentiates synthesis of thromboxane A2 in human platelets.
    Anderson WH; Mohammad SF; Chuang HY; Mason RG
    Adv Prostaglandin Thromboxane Res; 1980; 6():287-91. PubMed ID: 7386269
    [No Abstract]   [Full Text] [Related]  

  • 3. Thromboxane A2 biosynthesis in the ureter obstructed isolated perfused kidney of the rabbit.
    Morrison AR; Nishikawa K; Needleman P
    J Pharmacol Exp Ther; 1978 Apr; 205(1):1-8. PubMed ID: 633076
    [No Abstract]   [Full Text] [Related]  

  • 4. Synthesis of prostaglandins by vascular endothelial cells.
    Russo-Marie F
    Adv Nephrol Necker Hosp; 1985; 14():233-40. PubMed ID: 2983517
    [No Abstract]   [Full Text] [Related]  

  • 5. Nicotinic acid inhibits thromboxane synthesis in platelets.
    Vincent JE; Zijlstra FJ
    Prostaglandins; 1978 Apr; 15(4):629-36. PubMed ID: 674694
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of platelet aggregation and adenosine 3':5'-monophosphate on the synthesis of thromboxane B2 in human platelets.
    Lindgren JA; Claesson HE; Kindahl H; Hammarström S
    Adv Prostaglandin Thromboxane Res; 1980; 6():275-81. PubMed ID: 6247886
    [No Abstract]   [Full Text] [Related]  

  • 7. Inhibition of arachidonate metabolism by selected compounds in vitro with particular emphasis on the thromboxane A2 synthase pathway.
    Tobias LD; Hamilton JG
    Adv Prostaglandin Thromboxane Res; 1980; 6():453-6. PubMed ID: 6770605
    [No Abstract]   [Full Text] [Related]  

  • 8. In vivo inhibition of thromboxane biosynthesis by hydralazine.
    Greenwald JE; Wong LK; Alexander M; Bianchine JR
    Adv Prostaglandin Thromboxane Res; 1980; 6():293-5. PubMed ID: 7386270
    [No Abstract]   [Full Text] [Related]  

  • 9. Thromboxane A2-induced vascular endothelial cell damage and respiratory smooth muscle cell contraction: inhibition by flunarizine, a Ca2+-overload blocker.
    De Clerck F; Loots W; Somers Y; Van Gorp L; Verheyen A; Wouters L
    Arch Int Pharmacodyn Ther; 1985 Mar; 274(1):4-23. PubMed ID: 2990365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of an inhibitor of TXA2 synthesis and of PGE2 on the formation of 12-L-hydroxy-5,8,10-heptadecatrienoic acid in human platelets.
    Vincent JE; Zijlstra FJ; van Vliet H
    Adv Prostaglandin Thromboxane Res; 1980; 6():463-6. PubMed ID: 7386279
    [No Abstract]   [Full Text] [Related]  

  • 11. Generation of thromboxane A2 and aorta-contracting activity from platelets stimulated with modified C-reactive protein.
    Simpson RM; Prancan A; Izzi JM; Fiedel BA
    Immunology; 1982 Sep; 47(1):193-202. PubMed ID: 7118160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of platelet thromboxane A2 synthase activity by sodium 5-(3'-pyridinylmethyl)benzofuran-2-carboxylate.
    Gorman RR; Johnson RA; Spilman CH; Aiken JW
    Prostaglandins; 1983 Aug; 26(2):325-42. PubMed ID: 6316421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis of thromboxane B2 in incubates of dog platelet-rich plasma with arachidonic acid and its inhibition by different drugs.
    Chignard M; Vargaftig BB; Sors H; Dray F
    Biochem Biophys Res Commun; 1978 Dec; 85(4):1631-9. PubMed ID: 743319
    [No Abstract]   [Full Text] [Related]  

  • 14. Enzymatic synthesis of 15-hydroperoxythromboxane A2 and 12-hydroperoxy-5,8,10-heptadecatrienoic acid.
    Hammarström S
    J Biol Chem; 1980 Jan; 255(2):518-21. PubMed ID: 7356630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interference of transmethylation inhibitors with thromboxane synthesis in rat platelets: evidence for the requirement of a methyl transfer reaction in platelet activation.
    Lecompte T; Randon J; Chignard M; Vargaftig BB; Dray F
    Adv Prostaglandin Thromboxane Leukot Res; 1983; 11():441-7. PubMed ID: 6221560
    [No Abstract]   [Full Text] [Related]  

  • 16. Pharmacological studies on OKY-1581: a selective thromboxane synthetase inhibitor.
    Hiraku S; Wakitani K; Katsube N; Kawasaki A; Tsuboshima M; Naito J; Ujiie A; Komatsu H; Iizuka K
    Adv Prostaglandin Thromboxane Leukot Res; 1983; 11():241-4. PubMed ID: 6221530
    [No Abstract]   [Full Text] [Related]  

  • 17. The role of prostaglandins in platelet function.
    Marcus AJ
    Prog Hematol; 1979; 11():147-71. PubMed ID: 230534
    [No Abstract]   [Full Text] [Related]  

  • 18. Reciprocal regulation of human platelet cAMP levels by thromboxane A2 and prostacyclin.
    Gorman RR; Fitzpatrick FA; Miller OV
    Adv Cyclic Nucleotide Res; 1978; 9():597-609. PubMed ID: 208399
    [No Abstract]   [Full Text] [Related]  

  • 19. Selective and nonselective inhibition of thromboxane formation.
    FitzGerald GA; Oates JA
    Clin Pharmacol Ther; 1984 May; 35(5):633-40. PubMed ID: 6370554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An antithrombotic agent, NQ301, inhibits thromboxane A2 receptor and synthase activity in rabbit platelets.
    Jin YR; Cho MR; Lee KS; Lee JJ; Lim Y; Han XH; Oh KW; Hong JT; Yoo HS; Yun YP
    Basic Clin Pharmacol Toxicol; 2005 Sep; 97(3):162-7. PubMed ID: 16128910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.